Prevention of infective endocarditis: Guidelines from the American Heart Association
Walter R. Wilson(Lyell McEwin Hospital), David T. Durack(Duke Medical Center), Kathryn A. Taubert(Southwestern Medical Center), Matthew E. Levison, Robert O. Bonow(Northwestern University), David C. Goff(Andover Eye Associates), Patricia Ferrieri, Peter B. Lockhart(Carolinas Medical Center), Jane W. Newburger(Oregon Health & Science University), Larry M. Baddour(Mayo Clinic), Ann F. Bolger, Christopher H. Cabell(Pfizer (United States)), Jane C. Burns(Rady Children's Hospital-San Diego), Michael A. Gerber(Gerber Technology (United States)), Thomas J. Pallasch(Pallas (Germany)), Anne H. Rowley(Northwestern University), Michael H. Gewitz(New York Medical College), Timothy Gardner(American Heart Association), Brian L. Strom(Rutgers, The State University of New Jersey), Stanford T. Shulman(Lurie Children's Hospital), Robert S. Baltimore(American Heart Association), Lloyd Y. Tani(American Heart Association), Masato Takahashi(National Hospital Organization Hokkaido Medical Center)
Cited by 323
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k